{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T21:51:38Z","timestamp":1782510698517,"version":"3.54.5"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,9,4]],"date-time":"2015-09-04T00:00:00Z","timestamp":1441324800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00404-015-3858-z","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T04:27:33Z","timestamp":1441254453000},"page":"239-246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives"],"prefix":"10.1007","volume":"293","author":[{"given":"Nikolaos","family":"Vrachnis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Iavazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Iliodromiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Sifakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Alexandrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Siristatidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Grigoriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Botsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Creatsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,4]]},"reference":[{"key":"3858_CR1","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1158\/1940-6207.CAPR-10-0175","volume":"3","author":"M Pollak","year":"2010","unstructured":"Pollak M (2010) Metformin and other biguanides in oncology: advancing the research agenda. Cancer Prev Res 3:1060\u20131065","journal-title":"Cancer Prev Res"},{"key":"3858_CR2","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615\u20131625","journal-title":"Diabetes"},{"key":"3858_CR3","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","volume":"69","author":"HA Hirsch","year":"2009","unstructured":"Hirsch HA, Iliopoulos D, Tsichlis PN, Struhl K (2009) Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res 69:7507\u20137511","journal-title":"Cancer Res"},{"key":"3858_CR4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1665-2681(19)31495-4","volume":"11","author":"NM Abdel-Hamid","year":"2012","unstructured":"Abdel-Hamid NM, Nazmy MH, Abdel-Ghany MI, Nazmy WH (2012) Cytokines as important playmakers of experimental hepatocarcinogenesis confounded by diabetes. Ann Hepatol 11:118\u2013127","journal-title":"Ann Hepatol"},{"key":"3858_CR5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2337\/db11-0315","volume":"61","author":"Y Zhong","year":"2012","unstructured":"Zhong Y, Li J, Chen Y, Wang J et al (2012) Activation of endoplasmic reticulum stress by hyperglycemia is essential for muller cell-derived inflammatory cytokine production in diabetes. Diabetes 61:492\u2013504","journal-title":"Diabetes"},{"key":"3858_CR6","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1007\/s00125-011-2308-0","volume":"54","author":"BA Bartolo Di","year":"2012","unstructured":"Di Bartolo BA, Chan J, Bennett MR et al (2012) TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe\u2212\/\u2212 mice. Diabetologia 54:3157\u20133167","journal-title":"Diabetologia"},{"key":"3858_CR7","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.110.217117","volume":"106","author":"P Geraldes","year":"2010","unstructured":"Geraldes P, King GL (2010) Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 106:1319\u20131331","journal-title":"Circ Res"},{"key":"3858_CR8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.freeradbiomed.2011.10.483","volume":"52","author":"W Zhu","year":"2012","unstructured":"Zhu W, Jia Q, Wang Y et al (2012) The anthocyanin cyanidin-3-O-\u03b2-glucoside, a flavonoid, increases hepatic glutathione synthesis and protects hepatocytes against reactive oxygen species during hyperglycemia: involvement of a cAMP-PKA-dependent signaling pathway. Free Radic Biol Med 52:314\u2013327","journal-title":"Free Radic Biol Med"},{"issue":"14","key":"3858_CR9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1017\/S1462399411002109","volume":"11","author":"SM Schultze","year":"2012","unstructured":"Schultze SM, Hemmings BA, Niessen M, Tschopp O (2012) PI3K\/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis. Expert Rev Mol Med 11(14):e1","journal-title":"Expert Rev Mol Med"},{"key":"3858_CR10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539\u2013545","journal-title":"Lancet"},{"key":"3858_CR11","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860\u2013867","journal-title":"Nature"},{"key":"3858_CR12","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1001\/jama.283.19.2552","volume":"283","author":"SM Gapstur","year":"2000","unstructured":"Gapstur SM, Gann PH, Lowe W et al (2000) Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 283:2552\u20132558","journal-title":"JAMA"},{"key":"3858_CR13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/ajcn\/86.3.823S","volume":"86","author":"F Xue","year":"2007","unstructured":"Xue F, Michels KB (2007) Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 86:823\u2013835","journal-title":"Am J Clin Nutr"},{"key":"3858_CR14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/978-0-387-78818-0_6","volume":"630","author":"A Hjart\u00e5ker","year":"2008","unstructured":"Hjart\u00e5ker A, Langseth H, Weiderpass E (2008) Obesity and diabetes epidemics: cancer repercussions. Adv Exp Med Biol 630:72\u201393","journal-title":"Adv Exp Med Biol"},{"key":"3858_CR15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0960-0760(01)00185-6","volume":"80","author":"DJ Liao","year":"2002","unstructured":"Liao DJ, Dickson RB (2002) Roles of androgens in the development, growth, and carcinogenesis of the mammary gland. J Steroid Biochem Mol Biol 80:175\u2013189","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3858_CR16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","volume":"92","author":"RK Ross","year":"2000","unstructured":"Ross RK, Paganini-Hill A, Wan PC, Pike MC (2000) Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst 92:328\u2013332","journal-title":"J Natl Cancer Inst"},{"key":"3858_CR17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1677\/erc.0.0060175","volume":"6","author":"TJ Key","year":"1999","unstructured":"Key TJ (1999) Serum oestradiol and breast cancer risk. Endocr Relat Cancer 6:175\u2013180","journal-title":"Endocr Relat Cancer"},{"key":"3858_CR18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-0030-1270450","volume":"43","author":"LW Cho","year":"2011","unstructured":"Cho LW, Kilpatrick ES, Keevil BG et al (2011) Insulin resistance variability in women with anovulatory and ovulatory polycystic ovary syndrome, and normal controls. Horm Metab Res 43:141\u2013145","journal-title":"Horm Metab Res"},{"key":"3858_CR19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1008909128110","volume":"10","author":"I Persson","year":"1999","unstructured":"Persson I, Weiderpass E, Bergkvist L et al (1999) Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes Control 10:253\u2013260","journal-title":"Cancer Causes Control"},{"key":"3858_CR20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/09513599809012842","volume":"12","author":"EM Rutanen","year":"1998","unstructured":"Rutanen EM (1998) Insulin-like growth factors in endometrial function. Gynecol Endocrinol 12:399\u2013406","journal-title":"Gynecol Endocrinol"},{"key":"3858_CR21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ijc.11529","volume":"108","author":"A Lukanova","year":"2004","unstructured":"Lukanova A, Lundin E, Micheli A et al (2004) Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer 108:425\u2013432","journal-title":"Int J Cancer"},{"key":"3858_CR22","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","volume":"90","author":"HA Risch","year":"1998","unstructured":"Risch HA (1998) Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90:1774\u20131786","journal-title":"J Natl Cancer Inst"},{"key":"3858_CR23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/BF00051703","volume":"7","author":"R Kaaks","year":"1996","unstructured":"Kaaks R (1996) Nutrition, hormones, and breast cancer: Is insulin the missing link? Cancer Causes Control 7:605\u2013625","journal-title":"Cancer Causes Control"},{"key":"3858_CR24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1470-2045(05)01736-5","volume":"6","author":"I Wolf","year":"2005","unstructured":"Wolf I, Sadetzki S, Catane R et al (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6:103\u2013111","journal-title":"Lancet Oncol"},{"key":"3858_CR25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1210\/edrv.21.3.0399","volume":"21","author":"HM Khandwala","year":"2000","unstructured":"Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215\u2013244","journal-title":"Endocr Rev"},{"key":"3858_CR26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0008-6363(96)88599-3","volume":"29","author":"A Kluge","year":"1995","unstructured":"Kluge A, Zimmermann R, Munkel B et al (1995) Insulin-like growth factor I is involved in inflammation linked angiogenic processes after microembolisation in porcine heart. Cardiovasc Res 29:407\u2013415","journal-title":"Cardiovasc Res"},{"key":"3858_CR27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/13813450902878054","volume":"115","author":"S Becker","year":"2009","unstructured":"Becker S, Dossus L, Kaaks R (2009) Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Arch Physiol Biochem 115:86\u201396","journal-title":"Arch Physiol Biochem"},{"key":"3858_CR28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/sj.ijo.0801282","volume":"24","author":"JE Nestler","year":"2000","unstructured":"Nestler JE (2000) Obesity, insulin, sex steroids and ovulation. Int J Obes Relat Metab Disord 24:71\u201373","journal-title":"Int J Obes Relat Metab Disord"},{"key":"3858_CR29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1079\/PNS200070","volume":"60","author":"R Kaaks","year":"2001","unstructured":"Kaaks R, Lukanova A (2001) Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 60:91\u2013106","journal-title":"Proc Nutr Soc"},{"key":"3858_CR30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1189\/jlb.0409230","volume":"86","author":"R Ramasamy","year":"2009","unstructured":"Ramasamy R, Yan SF, Schmidt AM (2009) RAGE: therapeutic target and biomarker of the inflammatory response the evidence mounts. J Leukoc Biol 86:505\u2013512","journal-title":"J Leukoc Biol"},{"key":"3858_CR31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","volume":"54","author":"A Jemal","year":"2004","unstructured":"Jemal A, Tiwari CG, Murray T et al (2004) Cancer statistics. Cancer J Clin 54:8\u201329","journal-title":"Cancer J Clin"},{"key":"3858_CR32","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/aje\/kwh161","volume":"159","author":"SS Coughlin","year":"2004","unstructured":"Coughlin SS, Calle EE, Teras LR et al (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160\u20131167","journal-title":"Am J Epidemiol"},{"key":"3858_CR33","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00125-007-0681-5","volume":"50","author":"E Friberg","year":"2007","unstructured":"Friberg E, Orsini N, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 50:1365\u20131374","journal-title":"Diabetologia"},{"key":"3858_CR34","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1023\/A:1008913619107","volume":"11","author":"E Salazar-Martinez","year":"2000","unstructured":"Salazar-Martinez E, Lazcano-Ponce EC, Lira-Lira GG et al (2000) Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women. Cancer Causes Control 11:707\u2013711","journal-title":"Cancer Causes Control"},{"key":"3858_CR35","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/aje\/kwi127","volume":"161","author":"WH Xu","year":"2005","unstructured":"Xu WH, Matthews CE, Xiang YB et al (2005) Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women. Am J Epidemiol 161:939\u2013947","journal-title":"Am J Epidemiol"},{"key":"3858_CR36","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00432-004-0587-2","volume":"130","author":"LM Berstein","year":"2004","unstructured":"Berstein LM, Kvatchevskaya JO, Poroshina TE et al (2004) Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer. J Cancer Res Clin Oncol 130:687\u2013693","journal-title":"J Cancer Res Clin Oncol"},{"key":"3858_CR37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2478\/v10039-009-0035-2","volume":"54","author":"M Gnacinska","year":"2009","unstructured":"Gnacinska M, Malgorzewicz S, Stojek M et al (2009) Role of adipokines in complications related to obesity: a review. Adv Med Sci 54:150\u2013157","journal-title":"Adv Med Sci"},{"key":"3858_CR38","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1210\/jc.2006-2614","volume":"92","author":"AJ Hanley","year":"2007","unstructured":"Hanley AJ, Bowden D, Wagenknecht LE et al (2007) Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. J Clin Endocrinol Metab 92:2665\u20132671","journal-title":"J Clin Endocrinol Metab"},{"key":"3858_CR39","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s00125-009-1508-3","volume":"52","author":"FM Finucane","year":"2009","unstructured":"Finucane FM, Luan J, Wareham NJ et al (2009) Correlation of the leptin: adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 52:2345\u20132349","journal-title":"Diabetologia"},{"key":"3858_CR40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ygyno.2010.07.007","volume":"119","author":"N Ashizawa","year":"2010","unstructured":"Ashizawa N, Yahata T, Quan J, Adachi S, Yoshihara K, Tanaka K (2010) Serum leptin\u2013adiponectin ratio and endometrial cancer risk in postmenopausal female subjects. Gynecol Oncol 119:65\u201369","journal-title":"Gynecol Oncol"},{"key":"3858_CR41","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1210\/jc.2003-031716","volume":"89","author":"L Dal Maso","year":"2004","unstructured":"Dal Maso L, Augustin LS, Karalis A et al (2004) Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 89:1160\u20131163","journal-title":"J Clin Endocrinol Metab"},{"key":"3858_CR42","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/hmg\/ddu552","volume":"24","author":"JN Painter","year":"2015","unstructured":"Painter JN, O\u2019Mara TA, Batra J et al (2015) Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk. Hum Mol Genet 24:1478\u20131492","journal-title":"Hum Mol Genet"},{"key":"3858_CR43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.812","volume":"43","author":"AB Spurdle","year":"2011","unstructured":"Spurdle AB, Thompson DJ, Ahmed S et al (2011) Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nat Genet 43:451\u2013454","journal-title":"Nat Genet"},{"key":"3858_CR44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/gyno.1996.0090","volume":"61","author":"H Gogas","year":"1996","unstructured":"Gogas H, Shapiro F, Aghajanian C et al (1996) The impact of diabetes mellitus on the toxicity of therapy for advanced ovarian cancer. Gynecol Oncol 61:22\u201326","journal-title":"Gynecol Oncol"},{"key":"3858_CR45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molonc.2009.01.008","volume":"2","author":"PA Fasching","year":"2009","unstructured":"Fasching PA, Gayther S, Pearce L et al (2009) Role of genetic polymorphisms and ovarian cancer susceptibility. Mol Oncol 2:171\u2013181","journal-title":"Mol Oncol"},{"key":"3858_CR46","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ygyno.2014.12.017","volume":"136","author":"AW Lee","year":"2015","unstructured":"Lee AW, Tyrer JP, Doherty JA et al (2015) Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study. Gynecol Oncol 136:542\u2013548","journal-title":"Gynecol Oncol"},{"key":"3858_CR47","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0959-8049(97)00011-7","volume":"33","author":"F Parazzini","year":"1997","unstructured":"Parazzini F, Moroni S, La Vecchia C et al (1997) Ovarian cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 33:1634\u20131637","journal-title":"Eur J Cancer"},{"key":"3858_CR48","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1023\/A:1020271000069","volume":"13","author":"E Weiderpass","year":"2002","unstructured":"Weiderpass E, Ye W, Vainio H et al (2002) Diabetes mellitus and ovarian cancer. Cancer Causes Control 13:759\u2013764","journal-title":"Cancer Causes Control"},{"key":"3858_CR49","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1634\/theoncologist.2009-0300","volume":"15","author":"K Hemminki","year":"2010","unstructured":"Hemminki K, Li X, Sundquist J, Sundquist K (2010) Risk of cancer following hospitalization for type 2 diabetes. Oncologist 15:548\u2013555","journal-title":"Oncologist"},{"key":"3858_CR50","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ygyno.2010.12.329","volume":"121","author":"A Bakhru","year":"2011","unstructured":"Bakhru A, Buckanovich R, Griggs J (2011) The impact of diabetes on survival in women with ovarian cancer. Gynecol Oncol 121:106\u2013111","journal-title":"Gynecol Oncol"},{"key":"3858_CR51","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1002\/cncr.25595","volume":"117","author":"L Bordeleau","year":"2011","unstructured":"Bordeleau L, Lipscombe L, Lubinski J, Hereditary Breast Cancer Clinical Study Group et al (2011) Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations. Cancer 117:1812\u20131818","journal-title":"Cancer"},{"key":"3858_CR52","doi-asserted-by":"crossref","unstructured":"Yakar S, Pennisi P, Zhao H, et al (2004) Circulating IGF-1 and its role in cancer: lessons from the IGF-1 gene deletion (LID) mouse. Novartis Found Symp 262:3\u20139 (discussion 9\u201318, 265\u2013268)","DOI":"10.1002\/0470869976.ch2"},{"key":"3858_CR53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11010-005-3078-0","volume":"274","author":"DC Seldin","year":"2005","unstructured":"Seldin DC, Landesman-Bollag E, Farago M et al (2005) CK2 as a positive regulator of Wnt signalling and tumourigenesis. Mol Cell Biochem 274:63\u201367","journal-title":"Mol Cell Biochem"},{"key":"3858_CR54","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/jnci\/89.18.1360","volume":"89","author":"L Wideroff","year":"1989","unstructured":"Wideroff L, Gridley G, Mellemkjaer L et al (1989) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89:1360\u20131365","journal-title":"J Natl Cancer Inst"},{"key":"3858_CR55","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ije\/28.5.816","volume":"28","author":"HA Weiss","year":"1999","unstructured":"Weiss HA, Brinton LA, Potischman NA et al (1999) Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 28:816\u2013823","journal-title":"Int J Epidemiol"},{"key":"3858_CR56","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/bjc.1997.289","volume":"75","author":"R Talamini","year":"1997","unstructured":"Talamini R, Franceschi S, Favero A et al (1997) Selected medical conditions and risk of breast cancer. Br J Cancer 75:1699\u20131703","journal-title":"Br J Cancer"},{"key":"3858_CR57","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.293.2.194","volume":"293","author":"SH Jee","year":"2005","unstructured":"Jee SH, Ohrr H, Sull JW et al (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293:194\u2013202","journal-title":"JAMA"},{"key":"3858_CR58","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00125-006-0207-6","volume":"49","author":"K Rapp","year":"2006","unstructured":"Rapp K, Schroeder J, Klenk J et al (2006) Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 49:945\u2013952","journal-title":"Diabetologia"},{"key":"3858_CR59","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2337\/dc06-0922","volume":"30","author":"P Stattin","year":"2007","unstructured":"Stattin P, Bjor O, Ferrari P et al (2007) Prospective study of hyperglycemia and cancer risk. Diab Care 30:561\u2013567","journal-title":"Diab Care"},{"key":"3858_CR60","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/aje\/kwf050","volume":"156","author":"PJ Mink","year":"2002","unstructured":"Mink PJ, Shahar E, Rosamond WD et al (2002) Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 156:349\u2013352","journal-title":"Am J Epidemiol"},{"key":"3858_CR61","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1002\/ijc.24609","volume":"125","author":"GC Kabat","year":"2009","unstructured":"Kabat GC, Kim M, Caan BJ et al (2009) Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer 125:2704\u20132710","journal-title":"Int J Cancer"},{"key":"3858_CR62","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ijc.22717","volume":"121","author":"SC Larsson","year":"2007","unstructured":"Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856\u2013862","journal-title":"Int J Cancer"},{"key":"3858_CR63","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2009.09.024","volume":"116","author":"LA Cantrell","year":"2010","unstructured":"Cantrell LA, Zhou C, Mendivil A et al (2010) Metformin is a potent inhibitor of endometrial cancer cell proliferation-implications for a novel treatment strategy. Gynecol Oncol 116:92\u201398","journal-title":"Gynecol Oncol"},{"key":"3858_CR64","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/AOG.0b013e3182393ab3","volume":"119","author":"IL Romero","year":"2012","unstructured":"Romero IL, McCormick A, McEwen KA et al (2012) Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity. Obstet Gynecol 119:61\u201367","journal-title":"Obstet Gynecol"},{"key":"3858_CR65","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1582-4934.2009.00954.x","volume":"15","author":"R Rattan","year":"2011","unstructured":"Rattan R, Giri S, Hartmann LC, Shridhar V (2011) Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner. J Cell Mol Med 15:166\u2013178","journal-title":"J Cell Mol Med"},{"key":"3858_CR66","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2174\/138161208784139765","volume":"14","author":"R Abe","year":"2008","unstructured":"Abe R, Yamagishi S (2008) AGE\u2013RAGE system and carcinogenesis. Curr Pharm Des 14:940\u2013945","journal-title":"Curr Pharm Des"},{"key":"3858_CR67","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","volume":"69","author":"HA Hirsch","year":"2009","unstructured":"Hirsch HA, Iliopoulos D, Tsichlis PN et al (2009) Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res 69:7507\u20137511","journal-title":"Cancer Res"},{"key":"3858_CR68","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2008.04.008","volume":"110","author":"WH Gotlieb","year":"2008","unstructured":"Gotlieb WH, Saumet J, Beauchamp MC et al (2008) In vitro metformin anti-neoplastic activity in epithelial ovarian cancer. Gynecol Oncol 110:246\u2013250","journal-title":"Gynecol Oncol"},{"key":"3858_CR69","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2337\/dc08-2175","volume":"32","author":"G Libby","year":"2009","unstructured":"Libby G, Donnelly LA, Donnan PT et al (2009) New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diab Care 32:1620\u20131625","journal-title":"Diab Care"},{"key":"3858_CR70","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10549-010-1224-1","volume":"126","author":"PJ Goodwin","year":"2011","unstructured":"Goodwin PJ, Stambolic V, Lemieux J et al (2011) Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents. Breast Cancer Res Treat 126:215\u2013220","journal-title":"Breast Cancer Res Treat"},{"key":"3858_CR71","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1055\/s-0031-1280780","volume":"43","author":"JA Teng","year":"2011","unstructured":"Teng JA, Hou RL, Li DL et al (2011) Glargine promotes proliferation of breast adenocarcinoma cell line MCF-7 via AKT activation. Horm Metab Res 43:519\u2013523","journal-title":"Horm Metab Res"},{"key":"3858_CR72","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00125-009-1444-2","volume":"52","author":"JM Jonasson","year":"2009","unstructured":"Jonasson JM, Ljung R, Talback M et al (2009) Insulin glargine use and short-term incidence of malignancies\u2014a population-based follow-up study in Sweden. Diabetologia 52:1745\u20131754","journal-title":"Diabetologia"},{"key":"3858_CR73","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s00125-009-1453-1","volume":"52","author":"Colhoun HM, SDRN Epidemiology Group","year":"2009","unstructured":"Colhoun HM, SDRN Epidemiology Group (2009) Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 52:1755\u20131765","journal-title":"Diabetologia"},{"key":"3858_CR74","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13058-015-0574-3","volume":"17","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Kwon H, Lee JW et al (2015) Metformin increases survival in hormone receptor-positive, Her2-positive breast cancer patients with diabetes. Breast Cancer Res 17:64","journal-title":"Breast Cancer Res"},{"key":"3858_CR75","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/cam4.259","volume":"3","author":"BA Oppong","year":"2014","unstructured":"Oppong BA, Pharmer LA, Oskar S et al (2014) The effect of metformin on breast cancer outcomes in patients with type 2 diabetes. Cancer Med 3:1025\u20131034","journal-title":"Cancer Med"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-015-3858-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-015-3858-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-015-3858-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T04:08:40Z","timestamp":1567138120000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-015-3858-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,4]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["3858"],"URL":"https:\/\/doi.org\/10.1007\/s00404-015-3858-z","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,4]]}}}